Ontology highlight
ABSTRACT: Background
Biological therapies are increasingly used to treat ulcerative colitis (UC).Aim
To compare the efficacy of biologics in adults with moderately-to-severely active UC, stratified by prior exposure to anti-tumour necrosis factor (anti-TNF) therapy.Methods
A systematic literature review was undertaken to identify studies of biologics approved for UC. Network meta-analysis was conducted for endpoints at induction and maintenance.Results
Seven studies were included in the meta-analysis of induction treatment for anti-TNF therapy-naïve patients. All biologics were more effective than placebo in inducing clinical response, clinical remission, and mucosal healing. Infliximab demonstrated a statistically significant improvement over adalimumab in clinical r
SUBMITTER: Vickers AD
PROVIDER: S-EPMC5077077 | biostudies-literature | 2016
REPOSITORIES: biostudies-literature